Prof. PhD Supervisor. LI Diangui

On February 12, 2025, Prof. PhD Supervisor. LI Diangui was officially appointed as a doctoral supervisor by The Asia Pacific School of Business, concurrently serving as the Academic Vice Dean in The Asia Pacific School of Business, the Academic Dean of the Joint Graduate School of Traditional Medicine. Vice Chairman of the Degree Committee.

Prof. PhD Supervisor. LI Diangui, member of the Academic Department of China Academy of Chinese Medical Sciences, national master of Chinese medicine, professor, chief physician, professor, and doctoral supervisor of Hebei Provincial Hospital of Traditional Chinese Medicine. He is an expert enjoying special allowance from the State Council, a teacher of the third and fourth batches of national old Chinese medicine experts in academic experience inheritance, and has won the honorary titles of National Model Worker, the first special contribution award for Chinese medicine inheritance, the director of a national excellent Chinese medicine hospital, the fourth national Chinese physician award, provincial excellent expert, and provincial outstanding contribution expert. He is a young and middle-aged expert with outstanding contributions in Hebei Province, deputy secretary and vice president of the Party Committee of Hebei Medical University, member of the sixth, seventh, and eighth provincial CPPCC, and representative of the tenth provincial people's congress. He has been engaged in clinical practice. After more than 40 years of clinical exploration, he has made breakthrough progress in the treatment of atrophic gastritis, chronic liver disease, and cirrhosis, and proposed the "four-step stomach regulation" method for the treatment of atrophic gastritis, namely, soothing the liver and harmonizing the stomach, promoting blood circulation and removing blood stasis, and strengthening the spleen and harmonizing the stomach. He pioneered the "turbid toxin theory", which can effectively treat atrophic gastritis, remove intestinal metaplasia, and cut off precancerous lesions. He developed a series of pure Chinese medicine prescriptions with remarkable efficacy, breaking the theoretical constraints of "gastric precancerous lesions are irreversible", and providing a new idea and new theory for the treatment of chronic atrophic gastritis precancerous lesions with traditional Chinese medicine. He has been practicing medicine for more than 40 years, and has treated more than 100,000 patients clinically, with a cure rate and efficiency at the leading level in China.

Social positions: Chairman of the Li Shizhen Research Branch of the Chinese Association of Traditional Chinese Medicine, Vice Chairman of the Spleen and Stomach Disease Branch of the Chinese Association of Traditional Chinese Medicine.

Awards

Provincial, municipal, and departmental science and technology progress awards

Doctor's expertise

He pioneered the turbid toxin theory, guiding the treatment of spleen and stomach diseases, especially chronic atrophic gastritis, intestinal metaplasia and dysplasia (intraepithelial neoplasia) and other gastric precancerous lesions, refractory Helicobacter pylori infection, chronic liver disease, cirrhosis, and digestive system tumors.

Practice location

Hebei Provincial Hospital of Traditional Chinese Medici